The lack of an increase in GFAP in the absence of TYROBP led us to specifically interrogate other astrocytic markers often associated with neurodegenerative disease and neuroinflammation, i.e., “neurotoxic reactive astrocytes” [79, 80]. Here, GFAP is linked to neurodegenerative disease.